drugset
drugset / Trial / NCT01217918

Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects

NCT01217918 ↗

Phase 1 Completed 30 enrolled Pfizer
RandomizedParallel-groupDouble-blindBasic science

Summary

Study A6631027 will evaluate the safety, tolerability and pharmacokinetics of PH-797804 when administered to healthy Japanese subjects once a day (QD) for 10 days.

Timeline

Start
2010-10
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject PH-797804 Small molecule 1 mg Oral
Subject PH-797804 Small molecule 5 mg Oral
Subject PH-797804 Small molecule 10 mg Oral

Indications

No indication recorded.